232 related articles for article (PubMed ID: 31771951)
1. The role of noncoding mutations in blood cancers.
Rahman S; Mansour MR
Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31771951
[TBL] [Abstract][Full Text] [Related]
2. The Genome in a Three-Dimensional Context: Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer.
Rovirosa L; Ramos-Morales A; Javierre BM
Front Immunol; 2020; 11():592087. PubMed ID: 33117405
[TBL] [Abstract][Full Text] [Related]
3. Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
Heidenreich B; Kumar R
Int J Cancer; 2017 Sep; 141(5):867-876. PubMed ID: 28407294
[TBL] [Abstract][Full Text] [Related]
4. Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies.
Li K; Zhang Y; Liu X; Liu Y; Gu Z; Cao H; Dickerson KE; Chen M; Chen W; Shao Z; Ni M; Xu J
Cancer Discov; 2020 May; 10(5):724-745. PubMed ID: 32188707
[TBL] [Abstract][Full Text] [Related]
5. The Role of Noncoding Variants in Heritable Disease.
French JD; Edwards SL
Trends Genet; 2020 Nov; 36(11):880-891. PubMed ID: 32741549
[TBL] [Abstract][Full Text] [Related]
6. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
Cornish AJ; Hoang PH; Dobbins SE; Law PJ; Chubb D; Orlando G; Houlston RS
Blood Adv; 2019 Jan; 3(1):21-32. PubMed ID: 30606723
[TBL] [Abstract][Full Text] [Related]
7. Super-Enhancers Dysregulations in Hematological Malignancies.
Belloucif Y; Lobry C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
[TBL] [Abstract][Full Text] [Related]
8. Functional annotation of noncoding sequence variants.
Ritchie GR; Dunham I; Zeggini E; Flicek P
Nat Methods; 2014 Mar; 11(3):294-6. PubMed ID: 24487584
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes.
Cao X; Huber S; Ahari AJ; Traube FR; Seifert M; Oakes CC; Secheyko P; Vilov S; Scheller IF; Wagner N; Yépez VA; Blombery P; Haferlach T; Heinig M; Wachutka L; Hutter S; Gagneur J
Genome Med; 2024 May; 16(1):70. PubMed ID: 38769532
[TBL] [Abstract][Full Text] [Related]
10. Blood disease-causing and -suppressing transcriptional enhancers: general principles and
Bresnick EH; Johnson KD
Blood Adv; 2019 Jul; 3(13):2045-2056. PubMed ID: 31289032
[TBL] [Abstract][Full Text] [Related]
11. Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.
Zhou S; Treloar AE; Lupien M
Cancer Discov; 2016 Nov; 6(11):1215-1229. PubMed ID: 27807102
[TBL] [Abstract][Full Text] [Related]
12. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.
Diederichs S; Bartsch L; Berkmann JC; Fröse K; Heitmann J; Hoppe C; Iggena D; Jazmati D; Karschnia P; Linsenmeier M; Maulhardt T; Möhrmann L; Morstein J; Paffenholz SV; Röpenack P; Rückert T; Sandig L; Schell M; Steinmann A; Voss G; Wasmuth J; Weinberger ME; Wullenkord R
EMBO Mol Med; 2016 May; 8(5):442-57. PubMed ID: 26992833
[TBL] [Abstract][Full Text] [Related]
13. Alterations in transcriptional networks in cancer: the role of noncoding somatic driver mutations.
Doane AS; Elemento O
Curr Opin Genet Dev; 2022 Aug; 75():101919. PubMed ID: 35609422
[TBL] [Abstract][Full Text] [Related]
14. The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.
Lancho O; Herranz D
Trends Cancer; 2018 Dec; 4(12):810-822. PubMed ID: 30470303
[TBL] [Abstract][Full Text] [Related]
15. IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.
Wang J; Dayem Ullah AZ; Chelala C
Nucleic Acids Res; 2018 May; 46(8):e47. PubMed ID: 29390075
[TBL] [Abstract][Full Text] [Related]
16. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
17. Gene variants in noncoding regions and their possible consequences.
Wang GJ; Yang P; Xie HG
Pharmacogenomics; 2006 Mar; 7(2):203-9. PubMed ID: 16515399
[TBL] [Abstract][Full Text] [Related]
18. Variation in the Untranslated Genome and Susceptibility to Infections.
Ramsuran V; Ewy R; Nguyen H; Kulkarni S
Front Immunol; 2018; 9():2046. PubMed ID: 30245696
[TBL] [Abstract][Full Text] [Related]
19. An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
Wang H; Li W; Guo R; Sun J; Cui J; Wang G; Hoffman AR; Hu JF
Int J Cancer; 2014 Dec; 135(12):2783-94. PubMed ID: 24752773
[TBL] [Abstract][Full Text] [Related]
20. Regulatory variation: an emerging vantage point for cancer biology.
Li L; Lorzadeh A; Hirst M
Wiley Interdiscip Rev Syst Biol Med; 2014; 6(1):37-59. PubMed ID: 24254976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
